Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cycles
- 1 June 2003
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 79 (6) , 1461-1463
- https://doi.org/10.1016/s0015-0282(03)00388-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched studyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2002
- Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocolArchiv für Gynäkologie, 2001
- The Role of Gonadotropin-Releasing Hormone Antagonists in In Vitro FertilizationSeminars in Reproductive Medicine, 2001
- Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trialHuman Reproduction, 2001
- Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulationHuman Reproduction, 2001
- Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulationFertility and Sterility, 2001
- Embryo implantation and GnRH antagonistsHuman Reproduction, 2000
- The LHRH antagonist Cetrorelix: a reviewHuman Reproduction Update, 2000
- Embryo implantation and GnRH antagonistsHuman Reproduction, 2000
- Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyteThe Lancet, 1992